These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 12174434

  • 1. [The CBO professional guideline 'monoclonal gammopathy' (paraproteinemia) (revision)].
    Buiting AM, Wijermans PW.
    Ned Tijdschr Geneeskd; 2002 Jul 27; 146(30):1406-11. PubMed ID: 12174434
    [Abstract] [Full Text] [Related]

  • 2. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
    Elis A, Radnay J, Shapiro H, Itzhaky D, Manor Y, Lishner M.
    Isr Med Assoc J; 2006 Dec 27; 8(12):840-2. PubMed ID: 17214099
    [Abstract] [Full Text] [Related]

  • 3. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.
    International Myeloma Working Group.
    Br J Haematol; 2003 Jun 27; 121(5):749-57. PubMed ID: 12780789
    [Abstract] [Full Text] [Related]

  • 4. [Management of monoclonal gammopathy].
    Huijgens PC, Zweegman S.
    Ned Tijdschr Geneeskd; 2002 Jul 27; 146(30):1401-2. PubMed ID: 12174432
    [Abstract] [Full Text] [Related]

  • 5. [Monoclonal gammopathy--multiple myeloma].
    Dietzfelbinger H.
    MMW Fortschr Med; 2005 Jun 16; 147(24):32-3, 35-6. PubMed ID: 16001531
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic criteria of multiple myeloma.
    Kyle RA.
    Hematol Oncol Clin North Am; 1992 Apr 16; 6(2):347-58. PubMed ID: 1582977
    [Abstract] [Full Text] [Related]

  • 7. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O, Heider U, Zavrski I, Possinger K.
    Haematologica; 2001 Aug 16; 86(8):837-43. PubMed ID: 11522540
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA, Rajkumar SV.
    Br J Haematol; 2007 Dec 16; 139(5):730-43. PubMed ID: 18021088
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA, San-Miguel JF, Mateos MV, Rajkumar SV.
    Hematol Oncol Clin North Am; 2014 Oct 16; 28(5):775-90. PubMed ID: 25212882
    [Abstract] [Full Text] [Related]

  • 10. [The clinical significance of M proteins].
    Sasaki R.
    Rinsho Byori; 2001 Jul 16; 49(7):678-81. PubMed ID: 11519130
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The risk of a multiple myeloma in patients with paraproteinemia: a myeloma risk score developed in the region of the Comprehensive Cancer Center West].
    Schaar CG, Ong F, Snijder S, Wijermans PW, Franck PF, Kluin-Nelemans JC.
    Ned Tijdschr Geneeskd; 1998 Jul 11; 142(28):1591-5. PubMed ID: 9763839
    [Abstract] [Full Text] [Related]

  • 13. [Determination of interleukin-6 messenger RNA as malignant progression index in monoclonal gammapathy of undetermined significance].
    Mancini R, Palange M, Dionisi MG, De Angelis V, Matteocci A, Strano L.
    Recenti Prog Med; 1999 Oct 11; 90(10):522-6. PubMed ID: 10592737
    [Abstract] [Full Text] [Related]

  • 14. [A long-term observation of development from monoclonal gammopathy of undetermined significance (MGUS) into primary amyloidosis].
    Kanoh T, Yago K, Okuma M.
    Rinsho Ketsueki; 1990 Oct 11; 31(10):1740-4. PubMed ID: 2255066
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Monoclonal gammopathies: differential diagnosis with bone marrow biopsy].
    Faravelli A, Ponzoni M, Zoldan MC, Ricci D, Camba L.
    Pathologica; 1994 Jun 11; 86(3):258-66. PubMed ID: 7808796
    [Abstract] [Full Text] [Related]

  • 17. Monoclonal gammopathy of undetermined significance: why identification of these patients and assessment of their skeletons is important.
    Berenson JR, Yellin O.
    Clin Lymphoma Myeloma; 2009 Aug 11; 9(4):311-5. PubMed ID: 19717382
    [Abstract] [Full Text] [Related]

  • 18. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
    Uchida M, Taida N, Kanao M, Kagamihara H, Kuwajima M.
    Rinsho Byori; 2004 Jul 11; 52(7):574-9. PubMed ID: 15344556
    [Abstract] [Full Text] [Related]

  • 19. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
    Ng AP, Wei A, Bhurani D, Chapple P, Feleppa F, Juneja S.
    Haematologica; 2006 Jul 11; 91(7):972-5. PubMed ID: 16818287
    [Abstract] [Full Text] [Related]

  • 20. The value of the bone marrow plasma cell cytoplasmic light chain ratio in differentiating between multiple myeloma and monoclonal gammopathy of undetermined significance.
    Majumdar G, Grace RJ, Singh AK, Slater NG.
    Leuk Lymphoma; 1992 Dec 11; 8(6):491-3. PubMed ID: 1297481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.